Eplerenone reduced aldosterone levels, prevented cortical thinning, and reduced apoptosis in SHRs, suggesting that MR antagonism can protect against aldosterone-induced brain damage in hypertension. This evidence concerns the gene NR3C2 and hypertensive disorder.